Ellington Management Group’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-7,907
| Closed | -$239K | – | 554 |
|
|
2019
Q1 | $239K | Buy |
+7,907
| New | +$239K | 0.04% | 404 |
|
|
2016
Q1 | – | Sell |
-11,049
| Closed | -$422K | – | 492 |
|
|
2015
Q4 | $422K | Sell |
11,049
-7,599
| -41% | -$290K | 0.15% | 177 |
|
|
2015
Q3 | $594K | Buy |
+18,648
| New | +$594K | 0.17% | 180 |
|
|
2015
Q2 | – | Sell |
-4,900
| Closed | -$202K | – | 676 |
|
|
2015
Q1 | $202K | Buy |
+4,900
| New | +$202K | 0.04% | 596 |
|
|
2014
Q4 | – | Sell |
-9,500
| Closed | -$348K | – | 554 |
|
|
2014
Q3 | $348K | Buy |
9,500
+4,300
| +83% | +$158K | 0.24% | 125 |
|
|
2014
Q2 | $241K | Buy |
+5,200
| New | +$241K | 0.11% | 295 |
|
|
2014
Q1 | – | Sell |
-12,500
| Closed | -$477K | – | 600 |
|
|
2013
Q4 | $477K | Buy |
+12,500
| New | +$477K | 0.17% | 190 |
|